The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
X-linked adrenoleukodystrophy in women: a cross-sectional cohort study
Abstract
X-linked adrenoleukodystrophy is the most common peroxisomal disorder. The disease is caused by mutations in the ABCD1 gene that encodes the peroxisomal transporter of very long-chain fatty acids. A defect in the ABCD1 protein results in elevated levels of very long-chain fatty acids in plasma and tissues. The clinical spectrum in males with X-linked adrenoleukodystrophy has been well described and ranges from isolated adrenocortical insufficiency and slowly progressive myelopathy to devastating cerebral demyelination. As in many X-linked diseases, it was assumed that female carriers remain asymptomatic and only a few studies addressed the phenotype of X-linked adrenoleukodystrophy carriers. These studies, however, provided no information on the prevalence of neurological symptoms in the entire population of X-linked adrenoleukodystrophy carriers, since data were acquired in small groups and may be biased towards women with symptoms. Our primary goal was to investigate the symptoms and their frequency in X-linked adrenoleukodystrophy carriers. The secondary goal was to determine if the X-inactivation pattern of the ABCD1 gene was associated with symptomatic status. We included 46 X-linked adrenoleukodystrophy carriers in a prospective cross-sectional cohort study. Our data show that X-linked adrenoleukodystrophy carriers develop signs and symptoms of myelopathy (29/46, 63%) and/or peripheral neuropathy (26/46, 57%). Especially striking was the occurrence of faecal incontinence (13/46, 28%). The frequency of symptomatic women increased sharply with age (from 18% in women <40 years to 88% in women >60 years of age). Virtually all (44/45, 98%) X-linked adrenoleukodystrophy carriers had increased very long-chain fatty acids in plasma and/or fibroblasts, and/or decreased very long-chain fatty acids beta-oxidation in fibroblasts. We did not find an association between the X-inactivation pattern and symptomatic status. We conclude that X-linked adrenoleukodystrophy carriers develop an adrenomyeloneuropathy-like phenotype and there is a strong association between symptomatic status and age. X-linked adrenoleukodystrophy should be considered in the differential diagnosis in women with chronic myelopathy and/or peripheral neuropathy (especially with early faecal incontinence). ABCD1 mutation analysis deserves a place in diagnostic protocols for chronic non-compressive myelopathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is becoming increasingly recognized that the majority of women are not merely carriers, but may develop some degree of myeloneuropathy leading to gait, bowel, and bladder dysfunction [14,15,63].”
From Structure and Function of the ABCD1 Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of Adrenoleukodystrophy (2022) · cites this paper as [14]
In the citing paper
“Peripheral neuropathy is a common feature of ALD but is rarely the presenting symptom.7,14-16”
From International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy (2022) · cites this paper as [7]
In the citing paper
“Female patients with ALD remain asymptomatic in childhood and adolescence, while in adulthood, myeloneuropathy symptoms can arise.7,14”
From International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy (2022) · cites this paper as [7]
In the citing paper
“Women develop myeloneuropathy; men can develop all 3 syndromes.7-9”
From International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy (2022) · cites this paper as [7]
In the citing paper
“It was recently reported that all male and possibly even most female patients will develop at least some symptoms of AMN late in life and thus AMN has a near 100% lifetime penetrance.12,14,23”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [12]
In the citing paper
“A recent prospective cross-sectional cohort study including 46 heterozygous X-ALD females reported that 18% of women under the age of 40 years had symptoms but in the age group 60 years or older, 88% were symptomatic.12”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [12]
In the citing paper
“However, the majority of female carriers have elevated plasma VLCFA levels, although to a lesser extent than male patients, and the rate of beta-oxidation of VLCFAs was found to be decreased in fibroblasts.12”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [12]
In the citing paper
“During recent more detailed studies, it became apparent that a high number, if not all, of the heterozygous females develop at least some symptoms of AMN and that the severity of symptoms increases with age.12,24,89”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [12]
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Aaronson, N. K., Muller, M., Cohen, P. D. A., Essink-Bot, M.-L., Fekkes, M., Sanderman, R., Sprangers, M. A. G., te Velde, A., & Verrips, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00097-3 · Cited by 2,276
X-inactivation profile reveals extensive variability in X-linked gene expression in females
Carrel, L., & Willard, H. F. (2005) · Nature · doi:10.1038/nature03479 · Cited by 2,097
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
Ashworth, B. (1964) · PubMed · Cited by 1,475
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citationEngelen, M., Kemp, S., de Visser, M., van Geel, B. M., Wanders, R. J., Aubourg, P., & Poll-The, B. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-51 · Cited by 562
Self-citationHereditary spastic paraplegia: clinical features and pathogenetic mechanisms
Salinas, S., Proukakis, C., Crosby, A., & Warner, T. T. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70258-8 · Cited by 474
Moser, H. (1981) · doi:10.1212/wnl.31.10.1241 · Cited by 396
Migeon, B. R., Moser, H. W., Moser, A. B., Axelman, J., Sillence, D., & Norum, R. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.5066 · Cited by 283
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters
van Roermund, C. W. T., Visser, W. F., IJlst, L., van Cruchten, A., Boek, M., Kulik, W., Waterham, H. R., & Wanders, R. J. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-110866 · Cited by 233
Self-citation
Research works printed but not linked: 1
- van Geel, 2000, Draagsterschap van X-gebonden adrenoleukodystrofie, Ned Tijdschr Geneeskd, 144, 1764
Cited by
Sorted by citations
Human disorders of peroxisome metabolism and biogenesis
Waterham, H. R., Ferdinandusse, S., & Wanders, R. J. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.015 · Cited by 384
Self-citationAdrenoleukodystrophy—Neuroendocrine pathogenesis and redefinition of natural history
Kemp, S., Huffnagel, I. C., Linthorst, G. E., Wanders, R. J., & Engelen, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.90 · Cited by 275
Self-citationTurk, B. R., Theda, C., Fatemi, A. S., & Moser, A. B. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10003 · Cited by 212
Peroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
Engelen, M., Kemp, S., & Poll-The, B.-T. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0486-0 · Cited by 187
Self-citationSkewed X-inactivation is common in the general female population
Shvetsova, E., Sofronova, A. A., Monajemi, R., Gagalova, K., Draisma, H. H. M., White, S. J., Santen, G. W. E., Lopes, S. M. C. D. S., Heijmans, B. T., van Meurs, J. B. J., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0291-3 · Cited by 165
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy
Engelen, M., van Ballegoij, W. J. C., Mallack, E. J., Van Haren, K. P., Köhler, W., Salsano, E., van Trotsenburg, A. S. P., Mochel, F., Sevin, C., Regelmann, M. O., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201374 · Cited by 156
Self-citationBerger, J., Wiesinger, C., & Eichler, F. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49590 · Cited by 140
Kemper, A. R., Brosco, J., Comeau, A. M., Green, N. S., Grosse, S. D., Jones, E., Kwon, J. M., Lam, W. K. K., Ojodu, J., Prosser, L. A., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.68 · Cited by 109
Newborn Screening for X-Linked Adrenoleukodystrophy
Moser, A., Jones, R., Hubbard, W., Tortorelli, S., Orsini, J., Caggana, M., Vogel, B., & Raymond, G. (2016) · International Journal of Neonatal Screening · doi:10.3390/ijns2040015 · Cited by 106
Disease progression in women with X-linked adrenoleukodystrophy is slow
Huffnagel, I. C., Dijkgraaf, M. G. W., Janssens, G. E., van Weeghel, M., van Geel, B. M., Poll-The, B. T., Kemp, S., & Engelen, M. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1008-6 · Cited by 100
Self-citationThe changing face of adrenoleukodystrophy
Zhu, J., Eichler, F., Biffi, A., Duncan, C. N., Williams, D. A., & Majzoub, J. A. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa013 · Cited by 78
van Geel, B. M., Poll‐The, B. T., Verrips, A., Boelens, J., Kemp, S., & Engelen, M. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9797-1 · Cited by 78
Self-citationFourcade, S., Ferrer, I., & Pujol, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.041 · Cited by 80
A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy
Wiens, K., Berry, S. A., Choi, H., Gaviglio, A., Gupta, A., Hietala, A., Kenney‐Jung, D., Lund, T., Miller, W., Pierpont, E. I., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61171 · Cited by 75
Huffnagel, I. C., van de Beek, M.-C., Showers, A. L., Orsini, J. J., Klouwer, F. C. C., Dijkstra, I. M. E., Schielen, P. C., van Lenthe, H., Wanders, R. J. A., Vaz, F. M., et al. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.10.012 · Cited by 71
Self-citationJaspers, Y. R. J., Ferdinandusse, S., Dijkstra, I. M. E., Barendsen, R. W., van Lenthe, H., Kulik, W., Engelen, M., Goorden, S. M. I., Vaz, F. M., & Kemp, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00690 · Cited by 69
Self-citationTreatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy
Gupta, A. O., Raymond, G., Pierpont, E. I., Kemp, S., McIvor, R. S., Rayannavar, A., Miller, B., Lund, T. C., & Orchard, P. J. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2124857 · Cited by 67
Self-citationEvaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina
Lee, S., Clinard, K., Young, S. P., Rehder, C. W., Fan, Z., Calikoglu, A. S., Bali, D. S., Bailey, D. B., Gehtland, L. M., Millington, D. S., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20356 · Cited by 67
Wanders, R. J. A., Vaz, F. M., Waterham, H. R., & Ferdinandusse, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-60204-8_5 · Cited by 76
Self-citationProgression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness
Huffnagel, I. C., van Ballegoij, W. J. C., van Geel, B. M., Vos, J. M. B. W., Kemp, S., & Engelen, M. (2018) · Brain · doi:10.1093/brain/awy299 · Cited by 67
Self-citationAdrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
Barendsen, R. W., Dijkstra, I. M. E., Visser, W. F., Alders, M., Bliek, J., Boelen, A., Bouva, M. J., van der Crabben, S. N., Elsinghorst, E., van Gorp, A. G. M., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00499 · Cited by 65
Self-citationAdrenoleukodystrophy: Guidance for adrenal surveillance in males identified by newborn screen
Regelmann, M. O., Kamboj, M. K., Miller, B. S., Nakamoto, J. M., Sarafoglou, K., Shah, S., Stanley, T. L., Marino, R., & Pediatric Endocrine Society Drug and Therapeutics/Rare Diseases Committee (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00920 · Cited by 61
Mallack, E. J., Gao, K., Engelen, M., & Kemp, S. (2022) · Cells · doi:10.3390/cells11020283 · Cited by 60
Self-citationTurgeon, C. T., Moser, A. B., Mørkrid, L., Magera, M. J., Gavrilov, D. K., Oglesbee, D., Raymond, K., Rinaldo, P., Matern, D., & Tortorelli, S. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.11.013 · Cited by 60
Weisfeld‐Adams, J. D., Sand, I. K., Honce, J. M., & LUBLIN, F. D. (2015) · Brain · doi:10.1093/brain/awu397 · Cited by 59
Lipids in the Physiopathology of Hereditary Spastic Paraplegias
Darios, F. D., Mochel, F., & Stévanin, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00074 · Cited by 55
Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
Ranea‐Robles, P., Launay, N., Ruíz, M., Calingasan, N. Y., Dumont, M., Naudí, A., Portero‐Otín, M., Pamplona, R., Ferrer, I., Beal, M. F., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708604 · Cited by 55
Endocrine Dysfunction in X-Linked Adrenoleukodystrophy
Burtman, E., & Regelmann, M. O. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.003 · Cited by 52
Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up
Matteson, J., Sciortino, S., Feuchtbaum, L., Bishop, T., Olney, R. S., & Tang, H. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7020022 · Cited by 50
C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man
van de Beek, M.-C., Dijkstra, I. M. E., van Lenthe, H., Ofman, R., Goldhaber-Pasillas, D., Schauer, N., Schackmann, M., Engelen-Lee, J.-Y., Vaz, F. M., Kulik, W., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154597 · Cited by 48
Self-citationLipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy
van de Beek, M.-C., Ofman, R., Dijkstra, I. M. E., Wijburg, F. A., Engelen, M., Wanders, R. J. A., & Kemp, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.003 · Cited by 48
Self-citationIntrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy
Gong, Y., Berenson, A., Laheji, F., Gao, G., Wang, D., Ng, C., Volak, A., Kok, R., Kreouzis, V., Dijkstra, I. M., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.079 · Cited by 45
Self-citationCasasnovas, C., Ruíz, M., Schlüter, A., Naudí, A., Fourcade, S., Veciana, M., Castañer, S., Albertí, A., Bargalló, N., Johnson, M. R., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00735-2 · Cited by 42
Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy
Jaspers, Y. R. J., Yska, H. A. F., Bergner, C. G., Dijkstra, I. M. E., Huffnagel, I. C., Voermans, M. M. C., Wever, E. J. M., Salomons, G. S., Vaz, F. M., Jongejan, A., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00605-9 · Cited by 49
Self-citationEnzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis
Schackmann, M. J. A., Ofman, R., Dijkstra, I. M. E., Wanders, R. J. A., & Kemp, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.005 · Cited by 41
Self-citationMetabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy
Raas, Q., van de Beek, M.-C., Forss‐Petter, S., Dijkstra, I. M. E., Deschiffart, A., Freshner, B. C., Stevenson, T. J., Jaspers, Y. R. J., Nagtzaam, L., Wanders, R. J. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142500 · Cited by 42
Self-citationMuneer, Z., Wiesinger, C., Voigtländer, T., Werner, H. B., Berger, J., & Forss-Petter, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108655 · Cited by 33
Seminotti, B., Grings, M., Tucci, P., Leipnitz, G., & Saso, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.785057 · Cited by 45
Kim, A., Kumar, K. R., Davis, R. L., Mallawaarachchi, A. C., Gayevskiy, V., Minoche, A. E., Walls, Z., Kim, H., Jang, M., Cowley, M. J., et al. (2019) · The Cerebellum · doi:10.1007/s12311-019-01038-0 · Cited by 39
Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy
van Ballegoij, W. J. C., van de Stadt, S. I. W., Huffnagel, I. C., Kemp, S., Willemse, E. A. J., Teunissen, C. E., & Engelen, M. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51188 · Cited by 35
Self-citationNewborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in Pennsylvania
Priestley, J. R. C., Adang, L. A., Drewes Williams, S., Lichter-Konecki, U., Menello, C., Engelhardt, N. M., DiPerna, J. C., DiBoscio, B., Ahrens-Nicklas, R. C., Edmondson, A. C., et al. (2022) · International Journal of Neonatal Screening · doi:10.3390/ijns8020024 · Cited by 35
Sex‐specific newborn screening for X‐linked adrenoleukodystrophy
Albersen, M., van der Beek, S. L., Dijkstra, I. M. E., Alders, M. M., Barendsen, R. W., Bliek, J., Boelen, A., Ebberink, M. S., Ferdinandusse, S., Goorden, S. M. I., et al. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12571 · Cited by 36
Self-citationBiase, I. D., Tortorelli, S., Kratz, L. E., Steinberg, S. J., Cusmano‐Ozog, K. P., & Braverman, N. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0713-9 · Cited by 35
Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy
Morató, L., Ruíz, M., Boada, J., Calingasan, N. Y., Galino, J., Guilera, C., Jové, M., Naudí, A., Ferrer, I., Pamplona, R., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.20 · Cited by 33
Manor, J., Chung, H.-L., Bhagwat, P., & Wangler, M. F. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24953 · Cited by 34
X-factors in human disease: impact of gene content and dosage regulation
Fang, H., Deng, X., & Distèche, C. M. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab221 · Cited by 29
Parents’ views on accepting, declining, and expanding newborn bloodspot screening
van der Pal, S. M., Wins, S., Klapwijk, J. E., van Dijk, T., Kater‐Kuipers, A., van der Ploeg, C. P. B., Jans, S. M. P. J., Kemp, S., Verschoof‐Puite, R. K., van den Bosch, L. J. M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272585 · Cited by 29
Self-citationRichmond, P. A., van der Kloet, F., Vaz, F. M., Lin, D., Uzozie, A., Graham, E., Kobor, M., Mostafavi, S., Moerland, P. D., Lange, P. F., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00520 · Cited by 29
Self-citationExpanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective
van Dijk, T., Kater‐Kuipers, A., Jansen, M. E., Dondorp, W., Blom, M., Kemp, S., Langeveld, M., Cornel, M. C., van der Pal, S. M., & Henneman, L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.706394 · Cited by 29
Self-citationLong-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study
Tran, C., Patel, J., Stacy, H., Mamak, E. G., Faghfoury, H., Raiman, J., Clarke, J. T. R., Blaser, S., & Mercimek-Mahmutoglu, S. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2017.02.006 · Cited by 29
Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies
Ma, C. Y., Li, C., Zhou, X., Zhang, Z., Jiang, H., Liu, H., Chen, H. J., Tse, H., Liao, C., & Lian, Q. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112214 · Cited by 31
Natural history of a cohort of ABCD 1 variant female carriers
Schirinzi, T., Vasco, G., Aiello, C., Rizzo, C., Sancesario, A., Romano, A., Favetta, M., Petrarca, M., Paone, L., Castelli, E., et al. (2019) · European Journal of Neurology · doi:10.1111/ene.13816 · Cited by 27
Fourcade, S., Goicoechea, L., Parameswaran, J., Schlüter, A., Launay, N., Ruíz, M., Seyer, A., Colsch, B., Calingasan, N. Y., Ferrer, I., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12869 · Cited by 28
Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need
Honey, M. I. J., Jaspers, Y. R. J., Engelen, M., Kemp, S., & Huffnagel, I. C. (2021) · Cells · doi:10.3390/cells10123427 · Cited by 28
Self-citationBonaventura, E., Alberti, L., Lucchi, S., Cappelletti, L., Fazzone, S., Cattaneo, E., Bellini, M., Izzo, G., Parazzini, C., Bosetti, A., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1072256 · Cited by 27
van Engen, C. E., Ofman, R., Dijkstra, I. M. E., van Goethem, T. J., Verheij, E., Varin, J., Vidaud, M., Wanders, R. J. A., Aubourg, P., Kemp, S., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.006 · Cited by 26
Self-citationHong, S.-A., Seo, J. H., Wi, S., Jung, E. S., Yu, J., Hwang, G., Yu, J. H., Baek, A., Park, S., Bae, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.022 · Cited by 27
Chen, H., Hsu, R., Chen, P.-W., Lee, N., Chiu, P., Hwu, W., & Chien, Y. (2022) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2022.100902 · Cited by 26
SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing
Rubegni, A., Battisti, C., Tessa, A., Cerase, A., Doccini, S., Malandrini, A., Santorelli, F. M., & Federico, A. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.069 · Cited by 26
Newborn screening for adrenoleukodystrophy: International experiences and challenges
Videbæk, C. S., Melgaard, L., Lund, A. M., & Grønborg, S. W. (2023) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2023.107734 · Cited by 28
Newborn Screening for X-Linked Adrenoleukodystrophy in Nebraska: Initial Experiences and Challenges
Baker, C. V., Keller, A. C., Lutz, R., Eveans, K., Baumert, K., DiPerna, J. C., & Rizzo, W. B. (2022) · International Journal of Neonatal Screening · doi:10.3390/ijns8020029 · Cited by 23
Longitudinal diffusion MRI as surrogate outcome measure for myelopathy in adrenoleukodystrophy
Huffnagel, I. C., van Ballegoij, W. J. C., Vos, J. M. B. W., Kemp, S., Caan, M. W. A., & Engelen, M. (2019) · Neurology · doi:10.1212/wnl.0000000000008572 · Cited by 22
Self-citationSpinal cord atrophy as a measure of severity of myelopathy in adrenoleukodystrophy
van de Stadt, S. I. W., van Ballegoij, W. J. C., Labounek, R., Huffnagel, I. C., Kemp, S., Nestrašil, I., & Engelen, M. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12226 · Cited by 21
Self-citationX-chromosome inactivation and its implications for human diseasePreprint
Gribnau, J. H., & Barakat, T. S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/076950 · Cited by 21
Farrell, P. M., Langfelder-Schwind, E., & Farrell, M. H. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.08.008 · Cited by 20
Beyond gait and balance: Urinary and bowel dysfunction in X-linked adrenoleukodystrophy
Corre, C. S., Grant, N., Sadjadi, R., Hayden, D., Becker, C., Gomery, P., & Eichler, F. S. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01596-1 · Cited by 19
Endocrine dysfunction in adrenoleukodystrophy
Engelen, M., Kemp, S., & Eichler, F. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00018-6 · Cited by 20
Self-citationMarchetti, D. P., Donida, B., da Rosa, H. T., Manini, P. R., Moura, D. J., Saffi, J., Deon, M., Mescka, C. P., Coelho, D. D. M., Jardim, L. B., et al. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.03.004 · Cited by 19
Pujol, A. (2015) · Endocrine development · doi:10.1159/000439340 · Cited by 17
Hofereiter, J., Smith, M. D., Seth, J., Tudor, K. I., Fox, Z., Emmanuel, A., Murphy, E., Lachmann, R. H., & Panicker, J. (2015) · JIMD Reports · doi:10.1007/8904_2015_414 · Cited by 18
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1
Come, J. H., Senter, T. J., Clark, M. P., Court, J. J., Gale-Day, Z. J., Gu, W., Krueger, E. B., Liang, J., Morris, M., Nanthakumar, S. S., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00944 · Cited by 16
ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
Volmrich, A. M., Cuénant, L. M., Forghani, I., Hsieh, S. L., & Shapiro, L. T. (2022) · The Application of Clinical Genetics · doi:10.2147/tacg.s359479 · Cited by 19
Schäfer, L., Roicke, H., Bergner, C., & Köhler, W. (2023) · Brain and Behavior · doi:10.1002/brb3.2878 · Cited by 14
An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency
Hannah‐Shmouni, F., & Stratakis, C. A. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9447-2 · Cited by 17
Marchetti, D. P., Reinhardt, L. S., Jacques, C. E. D., Guerreiro, G., Mescka, C. P., Deon, M., Coelho, D. D. M., Moura, D. J., Viario, A. G., Poletto, F. S., et al. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0626-1 · Cited by 17
Morales‐Romero, B., de Aledo‐Castillo, J. M. G., Sierra, C. F., Carreira, C. M., Bonet, C. Z., Fernández, R. M. S., Caro-Miró, M. A., Ramírez, A. A., López, R. M., & García‐Villoria, J. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100516 · Cited by 16
Clinical and Neuroimaging Spectrum of Peroxisomal Disorders
Tan, A. P., Gonçalves, F. G., Almehdar, A., & Soares, B. P. (2018) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000172 · Cited by 16
Cognitive Functions in Adult‐Onset Phenotypes of X‐Linked Adrenoleukodystrophy
Schäfer, L., Roicke, H., Fischer, M., Sühnel, A., & Köhler, W. (2021) · Annals of Neurology · doi:10.1002/ana.26141 · Cited by 16
Turk, B. R., Theda, C., Fatemi, A. S., & Moser, A. B. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.11.002 · Cited by 17
Evolution of adrenoleukodystrophy model systems
Ferrer, R. M., Heine, V. M., Kemp, S., & Engelen, M. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12357 · Cited by 14
Self-citationNot just carriers: experiences of X-linked female heterozygotes
Choi, J. N., Kane, T., Propst, L., Spencer, S., Kostialik, J., & Arjunan, A. (2021) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-021-02270-6 · Cited by 15
Counseling for personal health implications identified during reproductive genetic carrier screening
Gbur, S., Mauney, L. C., Gray, K. J., Wilkins-Haug, L. E., & Guseh, S. H. (2021) · Prenatal Diagnosis · doi:10.1002/pd.6033 · Cited by 15
Schackmann, M. J. A., Ofman, R., van Geel, B. M., Dijkstra, I. M. E., van Engelen, K., Wanders, R. J. A., Engelen, M., & Kemp, S. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.03.009 · Cited by 15
Self-citationWillemsen, M. A. A. P., Harting, I., & Wevers, R. A. (2016) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000266 · Cited by 15
Bessey, A., Chilcott, J. B., Leaviss, J., & Sutton, A. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0921-4 · Cited by 16
Adrenoleukodystrophy in the era of newborn screening
Eng, L., & Regelmann, M. O. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000515 · Cited by 15
ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis
Buda, A., Forss-Petter, S., Hua, R., Jaspers, Y., Lassnig, M., Waidhofer-Söllner, P., Kemp, S., Kim, P., Weinhofer, I., & Berger, J. (2023) · Biomolecules · doi:10.3390/biom13091333 · Cited by 14
Self-citationKettwig, M., Klemp, H. G., Nessler, S., Streit, F., Krätzner, R., Rosewich, H., & Gärtner, J. (2021) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12389 · Cited by 14
Biochemical Studies in Fibroblasts to Interpret Variants of Unknown Significance in the ABCD1 Gene
van de Stadt, S. I. W., Mooyer, P. A. W., Dijkstra, I. M. E., Dekker, C. J. M., Vats, D., Vera, M., Ruzhnikov, M. R. Z., van Haren, K., Tang, N., Koop, K., et al. (2021) · Genes · doi:10.3390/genes12121930 · Cited by 14
Self-citationSTAR syndrome is part of the differential diagnosis of females with anorectal malformations
Zárate, Y. A., Farrell, J. M., Alfaro, M. P., & ElHassan, N. O. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37078 · Cited by 13
Dong, B., Lv, W., Xu, L., Zhao, Y., Sun, X., Wang, Z., Cheng, B., Fu, Z., & Wang, Y. (2022) · International Journal of Endocrinology · doi:10.1155/2022/5479781 · Cited by 12
Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders
Subhashini, P., Krishna, S. J., Rani, G. U., Chander, N. S., Reddy, G. M., & Naushad, S. M. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy085 · Cited by 13
Kornbluh, A. B., Baldwin, A., Fatemi, A. S., Vanderver, A. L., Adang, L. A., van Haren, K. P., Sampson, J. B., Eichler, F., Sadjadi, R., Engelen, M., et al. (2024) · Neurology Genetics · doi:10.1212/nxg.0000000000200192 · Cited by 13
Self-citationRestless Legs Syndrome in X-linked adrenoleukodystrophy
Winkelman, J. W., Grant, N. R., Molay, F., Stephen, C. D., Sadjadi, R., & Eichler, F. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.02.008 · Cited by 12
Progression rate of myelopathy in X-linked adrenoleukodystrophy heterozygotes
Habekost, C. T., Pereira, F. D. S., Vargas, C. R., Coelho, D. D. M., Torrez, V. R., Oses, J. P., Portela, L. V., Schestatsky, P., Torres, V. F., Matte, Ú. D. S., et al. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9672-2 · Cited by 12
Promises and challenges of genomic newborn screening (NBS) – lessons from public health NBS programs
Mori, M., Chaudhari, B. P., Ream, M. A., & Kemper, A. R. (2024) · Pediatric Research · doi:10.1038/s41390-024-03689-0 · Cited by 11
Pierpont, E. I., Isaia, A., McCoy, E., Brown, S. J., Gupta, A. O., & Eisengart, J. B. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12581 · Cited by 12
Adult cerebral adrenoleukodystrophy and Addison's disease in a female carrier
Chen, X., Chen, Z., Huang, D., Liu, X., Gui, Q., & Yu, S. (2014) · Gene · doi:10.1016/j.gene.2014.04.056 · Cited by 11
Chen, Y.-J., Wang, M.-W., Dong, E.-L., Lin, X.-H., Wang, N., Zhang, Z.-Q., Lin, X., & Chen, W.-J. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.008 · Cited by 11
Metadata
- Authors
- Engelen, M., Barbier, M., Dijkstra, I. M. E., Schür, R., de Bie, R. M. A., Verhamme, C., Dijkgraaf, M. G. W., Aubourg, P. A., Wanders, R. J. A., van Geel, B. M., de Visser, M., Poll–The, B. T., & Kemp, S.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-29
- Volume
- 137
- Issue
- 3
- Pages
- 693-706
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2150643970
- Cited by
- 234
- References
- 48
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 23 · 2023: 10 · 2022: 28 · 2021: 35 · 2020: 19 · 2019: 18 · 2018: 18 · 2017: 9 · 2016: 14 · 2015: 16 · 2014: 11
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- female carriers, ABCD1 gene, peroxisomal disorders, very long chain fatty acids, adrenomyeloneuropathy, myelopathy, peripheral neuropathy, fecal incontinence, X chromosome inactivation, peroxisomal beta-oxidation, differential diagnosis
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, Member 1, Adrenoleukodystrophy, Adult, Age Factors, Aged, Cross-Sectional Studies, Evoked Potentials, Female, Heterozygote, Humans, Middle Aged, Peripheral Nervous System Diseases, Prospective Studies, Spinal Cord Diseases, Cohort Studies, ATP-Binding Cassette Transporters, X Chromosome Inactivation, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
